Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Urology Physician in San Francisco, CA
NPI: 1366461667Primary Practice Location
UCSF MEDICAL CENTER
1975 4th St, San Francisco, CA
Primary Employer
UCSF Medical Group Business Services
ucsfhealth.org
HQ Phone
Get M.D. Peter's Phone NumberMobile
Get M.D. Peter's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
NY State Medical License
1984
CA State Medical License
1980 - 2025
American Board of Urology
Urology
Georgetown University School Of Medicine
som.georgetown.edu
Medical School
Until 1979
New York Presbyterian Hospital (Cornell Campus)
Residency • Urology
1984 - 1986
UCSF School of Medicine
medschool.ucsf.edu
Residency • Urology
1981 - 1984
Residency • Surgery
1979 - 1981
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 218 | 288 |
| 2 | 99203New patient outpatient visit, total time 30-44 minutes | 142 | 142 |
| 3 | 55866Surgical removal of prostate and surrounding lymph nodes using an endoscope | 69 | 69 |
| 4 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 64 | 85 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 53 | 55 |
Treatment Trends for Prostate Cancer—Reply
Authors: Matthew Cooperberg
Publication Date: 2015-11
Prostate cancer mortality following active surveillance versus immediate radical prostatectomy
Authors: Grossfeld, Gary D, Li, Yu-Ping, Lubeck, Deborah P, Broering, Jeanette M, Mehta, Shilpa S, Carroll, Peter R
Journal: J Urol
Lead Sponsor: Progenics Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: 18F-DCFPyL Injection, DIAGNOSTIC_TEST: PET/CT imaging
Lead Sponsor: University of California, San Francisco
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: BEHAVIORAL: Experimental: Arm 2 (Resist. Exercise), BEHAVIORAL: Experimental: Arm 1 (Aerobic Exercise)
Lead Sponsor: Stanford University
Collaborators: University of Mississippi Medical Center
Intervention / Treatment: DRUG: [18F]-FTC-146
